Basic Information
Basic information for MIR9-3HG-218-16aa-2
Peptide Name MIR9-3HG-218-16aa-2
Genome Position chr15:89396710-89396757[+]
Species Human
Peptide Sequence MGECTLLYCYIFFSCS
Peptide Length 16
Unique No (MIR9-3HG-201-16aa-1,MIR9-3HG-205-16aa-1,MIR9-3HG-212-16aa-1,MIR9-3HG-213-16aa-1,MIR9-3HG-214-16aa-2,MIR9-3HG-219-16aa-2,MIR9-3HG-220-16aa-1,MIR9-3HG-221-16aa-1,MIR9-3HG-222-16aa-2,MIR9-3HG-226-16aa-3,MIR9-3HG-227-16aa-2,MIR9-3HG-233-16aa-2,MIR9-3HG-241-16aa-2,MIR9-3HG-246-16aa-2,MIR9-3HG-247-16aa-1,MIR9-3HG-251-16aa-2,MIR9-3HG-252-16aa-2,MIR9-3HG-253-16aa-2)
Grand Average of Hydropathicity 1.1438
Relative Molecular Mass 2150.5
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000657897;MIR9-3HG-218
Transcript Length 4308
Coding Ability 0.5104
DNA Sequence Corresponding to Peptide ATGGGGGAGTGCACTCTTCTATACTGTTATATTTTCTTTTCATGCTCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :